Royalty Report: Diagnostic, Drugs, Assay – Collection: 211874

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 5

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 5

Primary Industries

  • Diagnostic
  • Drugs
  • Assay
  • Antibody
  • Medical
  • Immune
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 211874

License Grant
Licensor grants to the Australian Licensee a non-transferable, non-exclusive, perpetual and irrevocable license under the Patent to make, have made, use, sell, offer to sell, and import canine heartworm test kit products (CHW Kits) that contain the anti-CHW monoclonal antibody from clone key DI 16 872.5 (the CHW Antibody) or any derivatives thereof created or developed by or for Licensee (the CHW Antibody Derivatives).

Licensor further grants a non-transferable, non-exclusive, perpetual and irrevocable license under the Patent to use, sell, offer to sell, and import: CHW Antibody contained in CHW Kits; and, CHW Antibody Derivatives contained in CHW Kits.

Licensee shall have no right to sublicense.

Licensor grants Licensee an immunity from suit for licensed products.

Licensor grants an exclusive, non-transferable, sublicensable (only to Licensee partners) license, to use and display  Japan Witness® trademark only for ICT lateral flow veterinary test kit products sold in Japan. With regard to this license, Licensee shall not, and shall have no right to, sell outside of Japan, or authorize its distributors, resellers, and OEMs to sell outside of Japan, ICT lateral flow veterinary test kit products bearing Japan Witness® trademark.

License Property
The patent is for Immunoassay for Anti-Dirofilaria Immitis Antibody.  

The biological materials are Anti-CHW MAb, clone key DI16872.5-USDA code E118.00, Rabbit Anti-CHW PAb-USDA code E019.00, Rabbit Anti-CPV PAb-USDA code E024.01, and, Anti-CPV MAb, clone key A1C2.32-USDA code E024.01.

The products are canine heartworm test kits.

Field of Use
Licensee is in the business of developing, manufacturing and marketing veterinary diagnostics and other animal health related products worldwide, including ICT lateral flow veterinary test kit products which, for purposes of this Agreement, shall mean all veterinary diagnostic products in ICT (immunochromatography strip assay) format.

IPSCIO Record ID: 28947

License Grant
Technology: Party A hereby grants to Party B of Australia the exclusive, non-transferable, royalty-bearing sublicensable right, for the Exclusive Period, under all Technology owned or controlled by Party A which Party A, (i) to Distribute Products in the Party B Territory, and (ii) to make and manufacture Products throughout the world.

Trademarks. Party A hereby grants to Party B the exclusive, non-transferable, royalty-free, sublicensable right, for the Exclusive Period, to use and display the Trademarks in the Party B Territory in connection with the Distribution of Products.

License Property
1.   Canine Heartworm Antigen Test Kit containing typically: 10 or 25 Pouches, each containing 1 test device and a packet of desiccant

  10 or 25 Pipettes

  1 Buffer Dropper Bottle, labeled

  1 Directions for Use Leaflet

Biologicals used in manufacture of the test device include: Canine Heartworm antiserum (Polyclonal) – USDA registered Product code   E019.00 Canine Heartworm monoclonal antibody, clone key DI 16 872-5, USDA registered product code E118-00

2.   Feline Leukemia Virus Antigen Test Kit containing  typically: 10 Pouches, each containing 1 test device, and a packet of desiccant

  10 Pipettes

  1 Buffer Dropper Bottle, labeled

  1 Directions For Use Leaflet

Biologicals used in manufacture of the test device include:

Anti-Feline Leukemia Virus monoclonal antibody, clone key 24-1A2

Anti-Feline Leukemia Virus monoclonal antibody, clone key 1111B10A5

Non Specific Blocker monoclonal antibody, clone key B56.1.3A1/48

3.   Canine Parvo Virus Antigen Test Kit containing typically:

5 Pouches, each containing 1 test device, and a packet of desiccant

  5 Pipettes

  1 Buffer Dropper Bottle, labeled

  1 Directions For Use Leaflet

Biologicals used in the manufacture of the test kit include:

  Anti-Parvo Virus monoclonal antibody, clone key A1C2.32

  Anti-Parvo Virus antiserum (Polyclonal) with USDA registered product

  code E024.01

  Non Specific Blocker monoclonal antibody, clone key B56.1.3A1/48

Field of Use
This Agreement pertains to the medical industry relating to veterinary products.

IPSCIO Record ID: 203391

License Grant
In furtherance of the settlement of the Lawsuit, Licensor is willing to license certain of its intellectual property to Licensee.

Licensor hereby grants to Licensee and its Affiliates a non-exclusive, royalty-bearing license to the Patent Rights, without the right to sublicense except as approved by Licensor in writing, to make, have made, use, sell and have sold Mab-based Licensed Products in the Territory, except products utilizing the format technology that is proprietary and that, as of today, is provided by Party A to Licensor in the test format in Licensor’s current Witness heartworm diagnostic products. For purposes of clarity, Licensor hereby acknowledges Licensee’s right to have such Mab-based Licensed Products or any component thereof manufactured by a third party. This license grant is limited only to Licensee’s own Mab-based Licensed Products whereas products which Licensee may distribute for other parties that may otherwise infringe the Patent Rights are specifically excluded, except as approved by Licensor in writing.

Licensor hereby also grants to Licensee and its Affiliates a non-exclusive, royalty-free license to the Patent Rights, without the right to sublicense except as approved by Licensor in writing, to make, have made, use, sell and have sold Di33-based Licensed Products in the Territory, except products utilizing the format technology that is proprietary and that, as of today, is provided by Party A to Licensor in the test format in Licensor’s current Witness heartworm diagnotic products. For purposes of clarity,  Licensor hereby acknowledges Licensee’s right to have such Di33-based Licensed Products or any component thereof manufactured by a third party. Furthermore, the Parties agree that, if a product qualifies as both a Mab-based Licensed Product and a Di33-based Licensed Product, it shall be subject to royalties. This license grant is limited only to Licensee’s own Di33-based Licensed Products whereas products which Licensee may distribute for other parties that may otherwise infringe the Patent Rights are specifically excluded, except as approved by Licensor in writing.

License Property
Patent Rights shall mean the ’631 Patent.  Licensor is the owner of United States Patent No. 4,789,631 issued on December 6, 1988, entitled “Immunoassay for Anti-Dirofilaria Immitis Antibody” (the ’631 Patent).

Licensed Products shall mean Mab-based Licensed Products and/or Di33-based Licensed Products.

Mab-based Licensed Products shall mean any heartworm antigen detection test product or part thereof having or using at least one monoclonal antibody that reacts with Dirofilaria immitis antigenic extract, including any said heartworm antigen detection test product or part thereof within the scope of a claim in the Patent Rights or manufactured by a process within the scope of a claim in the Patent Rights. For avoidance of doubt, the Parties agree that Licensees SOLO STEP® CH product and canine and feline reference laboratory heartworm antigen detection tests using such a monoclonal antibody are “Mab-based Licensed Products”.

Di33-based Licensed Products ” shall mean any heartworm antibody detection test product or part thereof using at least one recombinant Di33 protein, wherein a Di33 protein has properties as set forth in the ‘569 Patent, including any said heartworm antibody detection test product or part thereof within the scope of a claim in the Patent Rights or manufactured by a process within the scope of a claim in the Patent Rights.

Field of Use
This agreement pertains to health products for dogs, cats and horses relating to developing, manufacturing and marketing veterinary diagnostics, vaccines and other animal health related products worldwide.

IPSCIO Record ID: 121773

License Grant
This amendment clarifies rights and royalties for the licensed canine heartworm test.  Licensor grants a limited, nonsublicensable, nonassignable, nonexclusive license under U.S. Patent No. 4,789,631 to develop, make, sell, market, distribute and use the Binax Test.  
The FeLV Synbiotics Sublicensed Product is hereby licensed back to Binax for development, manufacture, sale and distribution anywhere in the world.
License Property
The grant is for a canine heartworm test.
Field of Use
This agreement pertains to the veterinary care industry.

IPSCIO Record ID: 163133

License Grant
Licensor grants a Sublicense to Licensee and its Affiliates, to use the Licensor Antibodies, Cell Lines and Derivatives for the purpose of making, having made, using, selling and having sold Licensee Products.  Licensor shall provide Licensee quantities of Licensor Antibodies or Cell Lines and Derivatives, and information relating thereto.  Licensor agrees to deliver additional viable aliquots of Cell Lines or Derivatives to replace any aliquots previously delivered, which have subsequently become incapable of producing Licensor Monoclonal Antibodies and which are the same as the Licensor Cell Lines or Derivatives previously received by Licensee.

In order to protect Licensees source of supply of the Cell Lines or Derivatives Licensor warrants and agrees that Licensor shall maintain the Cell Lines and Derivatives in such a manner as will best preserve the viability thereof, in accordance with established scientific procedures.

License Property
Licensor holds exclusive licenses with respect to the Antibodies. Licensor is a supplier of specialty reagents, immuno-assay test kits and molecular research products to customers involved in biomedical research, the biotechnology industry and pharmaceutical drug discovery.

Monoclonal Antibodies to Human Interferongamma:
        *1.       Antibody B133.5

         2.       Antibody 3C11C8

         3.       Antibody 2G1

Monoclonal Antibodies to Human Granulocyte Marophage-Colony Stimulating Factor:

         1.       Antibody 3092

         2.       Antibody 3034

         3.       Antibody 1089

         4.       Antibody 4117

         5.       Antibody 2118

         6.       Antibody 1028

Monoclonal Antibodies to Human Tumor Necrosis Factor-alpha:

         *1.      Antibody B154.7.1

         *2.      Antibody B154.9.1

Field of Use
The purpose for this agreement is for research use.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.